C133H139N49O11 — CID 157271060
2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-(4,6-dihydro-1H-pyrrolo[3,4-d]pyrazol-5-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-[3-[2-(dimethylamino)ethyl]-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-indazol-1-yl-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-(7-methoxy-3-oxo-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide (PubChem CID 157271060) has the molecular formula C133H139N49O11 and a molecular weight of 2599.91 g/mol. Its IUPAC name is 2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-(4,6-dihydro-1H-pyrrolo[3,4-d]pyrazol-5-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-[3-[2-(dimethylamino)ethyl]-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-indazol-1-yl-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-(7-methoxy-3-oxo-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide.
| Compound Name | 2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-(4,6-dihydro-1H-pyrrolo[3,4-d]pyrazol-5-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-[3-[2-(dimethylamino)ethyl]-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-indazol-1-yl-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-(7-methoxy-3-oxo-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide |
|---|---|
| PubChem CID | 157271060 |
| Molecular Formula | C133H139N49O11 |
| Molecular Weight | 2599.91 g/mol |
| Exact Mass | 2598.18 |
| IUPAC Name | 2-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-(4,6-dihydro-1H-pyrrolo[3,4-d]pyrazol-5-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-[3-[2-(dimethylamino)ethyl]-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-indazol-1-yl-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-(7-methoxy-3-oxo-1H-isoindol-2-yl)-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide;2-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)pyrimidine-4-carboxamide |
| SMILES | CN(C)CCn1c(=O)n(-c2nccc(C(=O)Nc3cnccc3N3CCNCC3)n2)c2ccccc21.COc1cccc(N2CCN(c3nccc(C(=O)Nc4cnccc4N4CCNCC4)n3)C2=O)c1.COc1cccc2c1CN(c1nccc(C(=O)Nc3cnccc3N3CCNCC3)n1)C2=O.O=C(Nc1cnccc1N1CCNCC1)c1ccnc(-n2cnc3ccccc32)n1.O=C(Nc1cnccc1N1CCNCC1)c1ccnc(-n2ncc3ccccc32)n1.O=C(Nc1cnccc1N1CCNCC1)c1ccnc(N2Cc3cn[nH]c3C2)n1 |
| InChI | InChI=1S/C25H29N9O2.C24H26N8O3.C23H23N7O3.2C21H20N8O.C19H21N9O/c1-31(2)15-16-33-21-5-3-4-6-22(21)34(25(33)36)24-28-10-7-18(30-24)23(35)29-19-17-27-9-8-20(19)32-13-11-26-12-14-32;1-35-18-4-2-3-17(15-18)31-13-14-32(24(31)34)23-27-8-5-19(29-23)22(33)28-20-16-26-7-6-21(20)30-11-9-25-10-12-30;1-33-20-4-2-3-15-16(20)14-30(22(15)32)23-26-8-5-17(28-23)21(31)27-18-13-25-7-6-19(18)29-11-9-24-10-12-29;30-20(26-17-13-23-7-6-18(17)28-11-9-22-10-12-28)16-5-8-24-21(27-16)29-14-25-15-3-1-2-4-19(15)29;30-20(26-17-14-23-7-6-19(17)28-11-9-22-10-12-28)16-5-8-24-21(27-16)29-18-4-2-1-3-15(18)13-25-29;29-18(24-15-10-21-3-2-17(15)27-7-5-20-6-8-27)14-1-4-22-19(25-14)28-11-13-9-23-26-16(13)12-28/h3-10,17,26H,11-16H2,1-2H3,(H,29,35);2-8,15-16,25H,9-14H2,1H3,(H,28,33);2-8,13,24H,9-12,14H2,1H3,(H,27,31);2*1-8,13-14,22H,9-12H2,(H,26,30);1-4,9-10,20H,5-8,11-12H2,(H,23,26)(H,24,29) |
| InChIKey | AYNUYGOYMXNXHQ-UHFFFAOYSA-N |
| XLogP | 9.41 |
| TPSA | 658.29 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 50 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 193 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2599.91 |
| LogP ≤ 5 | 9.41 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 50 |